81 results on '"Mikelis, Constantinos M."'
Search Results
2. Identification of Rho GEF and RhoA Activation by Pull-Down Assays
3. Investigating Epidermal Interactions Through an In Vivo Cutaneous Wound-Healing Assay
4. In Vivo Ear Sponge Lymphangiogenesis Assay
5. Murine Dermal Lymphatic Endothelial Cell Isolation
6. Matrigel Plug Assay for In Vivo Evaluation of Angiogenesis
7. In Vitro Spheroid Sprouting Assay of Angiogenesis
8. In Vitro Wound Healing Assays to Investigate Epidermal Migration
9. Abstract 3759: Impact of individual and combined deregulation of miR-143 and miR-506 on cytokinetic and morphometric parameters in A549 lung cancer cells
10. Supplemental Figure 6 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
11. Data from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
12. Supplemental Figure 1 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
13. Supplementary Movie 1 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
14. Supplementary Figures 1-6 from Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
15. Supplementary Movie 4 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
16. Supplemental Figure 2 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
17. Supplementary Movie 3 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
18. Data from Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
19. Data from Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
20. Data from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
21. Supplemental Figure 4 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
22. Supplementary Methods and Materials, Supplementary Figure Legends from Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
23. Supplementary Figures 1-6 from Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
24. Supplemental Figure 5 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
25. Supplemental Figure 3 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
26. Supplementary Methods and Materials, Supplementary Figure Legends from Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
27. Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles
28. Chlorotoxin and Lung Cancer: A Targeting Perspective for Drug Delivery
29. Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis
30. Endothelial‐specific nanodelivery of Rho kinase inhibitors: Targeting tumor angiogenesis and metastasis
31. Chlorinated Benzothiadiazines Inhibit Angiogenesis Through Suppression of VEGFR2 Phosphorylation
32. Angiopoietin-2-induced lymphatic endothelial cell migration drives lymphangiogenesis via the β1 integrin-RhoA-formin axis
33. Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis
34. Protein tyrosine phosphatase receptor-ζ1 deletion triggers defective heart morphogenesis in mice and zebrafish
35. MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential
36. Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders
37. Delayed Exercise-induced Upregulation of Angiogenic Proteins and Recovery of Motor Function after Photothrombotic Stroke in Mice
38. Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance
39. Role of bFGF in Acquired Resistance upon Anti-VEGF Therapy in Cancer
40. Glycolysis is integral to histamine‐induced endothelial hyperpermeability
41. Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer
42. Late Breaking Abstract - Anaplastic Lymphoma Kinase inhibition as an effective treatment strategy against the enhanced lung carcinogenesis and cancer angiogenesis related to decreased PTPRZ1 expression
43. An iPSC-Derived Neuron Model of CLN3 Disease Facilitates Small Molecule Phenotypic Screening
44. S1PR1 regulates the quiescence of lymphatic vessels by inhibiting laminar shear stress–dependent VEGF-C signaling
45. Pleiotrophin selectively binds to vascular endothelial growth factor receptor 2 and inhibits or stimulates cell migration depending on ανβ3 integrin expression
46. Assessing the Current State of Lung Cancer Chemoprevention: A Comprehensive Overview
47. Endothelial Small GTPase RhoA: A Potential Target for Anti‐angiogenic Therapy
48. Sema3F Suppresses Tumor Initiation Through Alteration of the Immunological Tumor Microenvironment
49. Anti-angiogenic effects of VEGF stimulation on endothelium deficient in phosphoinositide recycling
50. S1PR1 regulates the quiescence of lymphatic vessels by inhibiting laminar shear stress-dependent VEGF-C signaling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.